Abstract
Objective: To estimate the age-specific seroprevalence of hepatitis B surface antigen (HBsAg) in children upto 14 years of age.Methods: Equal number (115 each) of apparently healthy children of both sexes of different age groups i.e. < 1, 1–4, 5–9 and 10–14 years, attending pediatric outpatient services and Well Baby Clinic of the hospital were tested for HBsAg using ELISA test. Positive results were confirmed by a second ELISA.Results: Overall 4.35% (95%CI, 2.44 –6.25) of the 460 children tested were HBsAg positive. The prevalence rate was the highest (6.09%) in the 1–4 year age category. In the < 1, 5–9 and 10–14 year age groups it was 4.35%, 4.35% and 2.61% respectively. The overall male to female ratio was 2.1:1, with no significant difference in seropositivity rates (P = 0.816).The difference in the prevalence rates between the rural (4.84%) and urban populations (3.77%) was also statistically insignificant (P = 0.577).Conclusion: Average HBsAg positivity in the pediatric population in this region is 4.35% (95%CI, 2.44 –6.25). The prevalence progressively increases and peaks in the 1–4 years age group. It is least in 10–14 years age group.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
The World Health Report, Fighting Disease Fostering Development, Report of the Director General, WHO, 1996. Available from: URL: http://www.wma.net/. Accessed June 28,2003.
Mittal SK. Hepatitis B Vaccination: Myths and Controversies.Indian J Pediatr 2003; 70: 499–502.
Lodha R, Jain Y, Anand K, Kabra SK, Pandav CS. Hepatitis B in India: A review of disease epidemiology.Indian Peditar 2001; 38: 349–371.
John TJ, Abraham P. Hepatitis B in India: A Review of Disease Epidemiology.Indian Pediatr 2001; 38: 1318–1322.
Hepatitis B in India: Burden of disease analysis. InPrevention of Hepatitis B in India —an Overview, 2002. Available from http:/ / www.whqlibdoc.who.int/searo/2002/SEA-Hepat.-5.pdf. Accessed July 28,2003.
Sobeslavsky O. Prevalence of marker of hepatitis B virus infection in various countries, a WHO collaborative study.Bull WHO 1980; 58(4); 621–628.
Singh J, Bhatia R, Khare I, Patnaik SK, Biswas S, Lal Set al. Community studies on prevalence of HBsAg in two urban population of Southern India.Indian Pediatr 2000; 37: 149–152.
Thyagarajan SP, Jayaram S, Mohanavalli B. Prevalence of HBV in general population in India. In Sarin SK and Singhal AK, eds.Hepatitis B in India: Problems and prevention. New Delhi; CBS publications; 1996; 5–16.
Kant L, Hall AJ. Epidemiology of childhood Hepatitis B in India: Vaccination related issues.Indian J Pediatr 1995; 62: 635–653.
Pal SR, Chitkara NL, Choudhary S, Dutta DV, Deodhar SD, Chhuttani PN. Hepatitis B virus infection in Northern India.Bull WHO 1974; 51: 13–17
Tandon BN, Irshad M, Raja M, Mathur GP, Rao MN. Prevalence of HBsAg and anti-HBs in children and strategy suggested for immunization in India.Indian J Med Res 1991; 93: 337–339.
Dutta S, Shivananda PG, Chatterjee A. Prevalence of Hepatitis B surface antigen and antibody among hospital admitted patients in Manipal.Indian J Public Health 1994; 38: 108–112.
Jain RC, Bhat SD, Sangle S. Prevalence of Hepatitis Surface Antigen among rural population of Loni area in Ahmednagar district of Western Maharashtra.J Assoc Physicians India 1992; 40: 390–391.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Qamer, S., Shahab, T., Alam, S. et al. age-specific prevalence of hepatitis B surface antigen in pediatric population of Aligarh, North India. Indian J Pediatr 71, 965–967 (2004). https://doi.org/10.1007/BF02828107
Issue Date:
DOI: https://doi.org/10.1007/BF02828107